This company seems to have been delisted
Reason: Acquired by AbbVie
Last recorded trade on: April 12, 2024
Source: https://news.abbvie.com/2024-02-12-AbbVie-Completes-Acquisition-of-ImmunoGen
Reason: Acquired by AbbVie
Last recorded trade on: April 12, 2024
Source: https://news.abbvie.com/2024-02-12-AbbVie-Completes-Acquisition-of-ImmunoGen
ImmunoGen
IMGN
HK$245.14
Share price
0.00%
Change (1 day)
135.37%
Change (1 year)
Categories
ImmunoGen (IMGN) - Total debt
Total debt on the balance sheet as of September 2023 : HK$0.66 Billion
According to ImmunoGen 's latest financial reports the company's total debt is HK$0.66 Billion. A company’s total debt is the sum of all current and non-current debts.
ImmunoGen - Total debt on balance sheet (from 1996 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | HK$0.11 B | -18.67% |
| 2021-12-31 | HK$0.14 B | -20.93% |
| 2020-12-31 | HK$0.18 B | -11.42% |
| 2019-12-31 | HK$0.20 B | 1193.62% |
| 2018-12-31 | HK$16.16 M | 0.91% |
| 2017-12-31 | HK$16.01 M | |
| 2016-06-30 | HK$0.74 B | |
| 2001-06-30 | HK$0.06 M | -97.93% |
| 2000-06-30 | HK$3.06 M | 97.59% |
| 1999-06-30 | HK$1.55 M | 100.19% |
| 1998-06-30 | HK$0.77 M | -49.99% |
| 1997-06-30 | HK$1.54 M | -94.87% |
| 1996-06-30 | HK$30.18 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Seagen
SGEN | HK$0.89 B | 34.57% | 🇺🇸 USA |
 Amgen AMGN | HK$450.41 B | 67,943.40% | 🇺🇸 USA |
 Eli Lilly LLY | HK$302.33 B | 45,572.83% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | HK$402.20 B | 60,660.11% | 🇺🇸 USA |
 Johnson & Johnson JNJ | HK$410.15 B | 61,861.34% | 🇺🇸 USA |
 Pfizer PFE | HK$481.10 B | 72,579.95% | 🇺🇸 USA |
 Novartis NVS | HK$245.45 B | 36,980.52% | 🇨🇭 Switzerland |
 Sanofi SNY | HK$178.73 B | 26,901.66% | 🇫🇷 France |